ENTITY
Xiamen Amoytop Biotech Co Ltd

Xiamen Amoytop Biotech Co Ltd (688278 CH)

37
Analysis
Health Care • China
Xiamen Amoytop Biotech Co., Ltd. operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products. Xiamen Amoytop Biotech markets its products primarily throughout China with limited overseas.
more
Exchange Announcement • 02 Apr 2021 17:06

Tebao Bio: Announcement on the 2020 Annual Results and Cash Dividend Explaining Meeting (特宝生物:关于召开2020年度业绩及现金分红说明会的公告)

Exchange Announcement • 24 Dec 2020 16:45

Announcement Of Tebao Bio On Passing The Recognition Of High-Tech Enterprises (特宝生物关于通过高新技术企业认定的公告)

Exchange Announcement • 22 Dec 2020 16:05

Tebao Bio'S Announcement On Obtaining Government Subsidies (特宝生物关于获得政府补助的公告)

No more filings
x